Accelerating cures for cancer by integrating discoveries in biology with innovative technology

Our Portfolio


146 Research Grants

Over $125 Million Awarded


  • 23% Basic Research
  • 2% Clinical Research
  • 18% Technology Innovation
  • 10% Therapeutic Discovery
  • 47% Translational Science

Investments in 6 Companies

Over $20 Million Invested


  • 32.3% Diagnostics
  • 18.1% Cell & Gene Therapy
  • 19.9% Small Molecule Therapy
  • 29.8% Biologics

Over 60 Institutions

In 6 Countries


  • CANADA
  • NETHERLANDS
  • DENMARK
  • UNITED KINGDOM
  • FRANCE
  • USA

latest news


Research Spotlight: Alessandro Leal, and Jillian Phallen.

Read More

The Mark Foundation for Cancer Research funds Jackson Laboratory scientists

Read More

Research Spotlight: Shin Foong Ngiow

Read More